These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Innate Immune Sensing of Adeno-Associated Virus Vectors. Cao D; Byrne BJ; de Jong YP; Terhorst C; Duan D; Herzog RW; Kumar SRP Hum Gene Ther; 2024 Jul; 35(13-14):451-463. PubMed ID: 38887999 [TBL] [Abstract][Full Text] [Related]
4. Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer. Rogers GL; Suzuki M; Zolotukhin I; Markusic DM; Morel LM; Lee B; Ertl HC; Herzog RW J Innate Immun; 2015; 7(3):302-14. PubMed ID: 25612611 [TBL] [Abstract][Full Text] [Related]
5. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. Zhu J; Huang X; Yang Y J Clin Invest; 2009 Aug; 119(8):2388-98. PubMed ID: 19587448 [TBL] [Abstract][Full Text] [Related]
6. Effect of CpG Depletion of Vector Genome on CD8 Bertolini TB; Shirley JL; Zolotukhin I; Li X; Kaisho T; Xiao W; Kumar SRP; Herzog RW Front Immunol; 2021; 12():672449. PubMed ID: 34135899 [TBL] [Abstract][Full Text] [Related]
7. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver. Martino AT; Suzuki M; Markusic DM; Zolotukhin I; Ryals RC; Moghimi B; Ertl HC; Muruve DA; Lee B; Herzog RW Blood; 2011 Jun; 117(24):6459-68. PubMed ID: 21474674 [TBL] [Abstract][Full Text] [Related]
8. Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN. Shimizu K; Yamasaki S; Sakurai M; Yumoto N; Ikeda M; Mishima-Tsumagari C; Kukimoto-Niino M; Watanabe T; Kawamura M; Shirouzu M; Fujii SI Front Immunol; 2019; 10():1450. PubMed ID: 31293597 [TBL] [Abstract][Full Text] [Related]
9. IFN-alphabeta-mediated inflammatory responses and antiviral defense in liver is TLR9-independent but MyD88-dependent during murine cytomegalovirus infection. Hokeness-Antonelli KL; Crane MJ; Dragoi AM; Chu WM; Salazar-Mather TP J Immunol; 2007 Nov; 179(9):6176-83. PubMed ID: 17947693 [TBL] [Abstract][Full Text] [Related]
10. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation. Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K Front Immunol; 2018; 9():3070. PubMed ID: 30622542 [TBL] [Abstract][Full Text] [Related]
11. Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 Signaling. Puttur F; Francozo M; Solmaz G; Bueno C; Lindenberg M; Gohmert M; Swallow M; Tufa D; Jacobs R; Lienenklaus S; Kühl AA; Borkner L; Cicin-Sain L; Holzmann B; Wagner H; Berod L; Sparwasser T Cell Rep; 2016 Oct; 17(4):1113-1127. PubMed ID: 27760315 [TBL] [Abstract][Full Text] [Related]
12. Burn injury triggered dysfunction in dendritic cell response to TLR9 activation and resulted in skewed T cell functions. Shen H; de Almeida PE; Kang KH; Yao P; Chan CW PLoS One; 2012; 7(11):e50238. PubMed ID: 23189191 [TBL] [Abstract][Full Text] [Related]
14. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice. Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235 [TBL] [Abstract][Full Text] [Related]
15. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice. Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858 [TBL] [Abstract][Full Text] [Related]
16. Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9. Lee LM; Ji M; Sinha M; Dong MB; Ren X; Wang Y; Lowell CA; Ghosh S; Locksley RM; DeFranco AL PLoS One; 2016; 11(12):e0167693. PubMed ID: 27977701 [TBL] [Abstract][Full Text] [Related]
17. Essential role of pre-existing humoral immunity in TLR9-mediated type I IFN response to recombinant AAV vectors in human whole blood. Alakhras NS; Moreland CA; Wong LC; Raut P; Kamalakaran S; Wen Y; Siegel RW; Malherbe LP Front Immunol; 2024; 15():1354055. PubMed ID: 39007143 [TBL] [Abstract][Full Text] [Related]
18. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Yamaguchi T; Kawabata K; Koizumi N; Sakurai F; Nakashima K; Sakurai H; Sasaki T; Okada N; Yamanishi K; Mizuguchi H Hum Gene Ther; 2007 Aug; 18(8):753-62. PubMed ID: 17685831 [TBL] [Abstract][Full Text] [Related]
19. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus. Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804 [TBL] [Abstract][Full Text] [Related]